NCT07165535 Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network
| NCT ID | NCT07165535 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Milano Bicocca |
| Condition | Chronic Myeloid Leukemia (CML) |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2025-04-17 |
| Primary Completion | 2026-05-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2025-04-17 with a primary completion date of 2026-05-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of the study is to assess the impact of the organizational model of the hematology center on the quality of life of patients with CML estimated through standardized tools (EORTC QLQ-30, CML24) and through the patient's opinion regarding aspects of the quality of care.
Eligibility Criteria
Inclusion Criteria: * Subjects aged 18 years or older. * Subjects diagnosed with Chronic Myeloid Leukemia. * Subjects diagnosed with CML under care at the hematology outpatient clinics of the 21 REL centers. * Subjects followed at the reference hematology center for a minimum of 6 months. * Freely given informed consent obtained before the start of the study. Exclusion Criteria: * Subjects who have not given consent to participate in the study. * Subjects who do not meet the inclusion criteria.
Frequently Asked Questions
Who can join the NCT07165535 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Myeloid Leukemia (CML). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07165535 currently recruiting?
Yes, NCT07165535 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Milano Bicocca to inquire about joining.
Where is the NCT07165535 trial being conducted?
This trial is being conducted at Monza, Italy.
Who is sponsoring the NCT07165535 clinical trial?
NCT07165535 is sponsored by University of Milano Bicocca. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.